Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective

[Image: see text] The most advanced antiviral molecules addressing major SARS-CoV-2 targets (Main protease, Spike protein, and RNA polymerase), compared with proteins of other human pathogenic coronaviruses, may have a short-lasting clinical efficacy. Accumulating knowledge on the mechanisms underly...

Descripción completa

Detalles Bibliográficos
Autores principales: Pozzi, Cecilia, Vanet, Anne, Francesconi, Valeria, Tagliazucchi, Lorenzo, Tassone, Giusy, Venturelli, Alberto, Spyrakis, Francesca, Mazzorana, Marco, Costi, Maria P., Tonelli, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005815/
https://www.ncbi.nlm.nih.gov/pubmed/36857133
http://dx.doi.org/10.1021/acs.jmedchem.2c01229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005815/
https://www.ncbi.nlm.nih.gov/pubmed/36857133
http://dx.doi.org/10.1021/acs.jmedchem.2c01229

Ejemplares similares